Abstract

Cell therapy has shown beneficial effects on ventricular function and tissue regeneration in patients with acute and chronic myocardial infarction, although with diverse grades of variability in the results, possibly by proportion, subtype and cell cycle status. Objective: Identify and phenotypically characterize, via CXCR4 and SDF-1 expression, the bone marrow cell subpopulations that are mobilized into the bloodstream in patients with Acute Myocardial Infarction (AMI) and Acute Ischemia (AI) such as acute angina and Chronic Ischemia (CI) such as chronic stable angina, and also determine the cell cycle status of these cells. Method: Patients with AMI and AI were recruited in the ICCU, and patients with CI in the departments of cardiology and cardiovascular surgery. The quantification of cellular subpopulations was made by cytofluorometry with a FACS caliburcyto fluorometry (Becton Dickinson) with specific FITC-labeled anti human monoclonal antibodies against CD34, CD133, CD117, CD48, CXCR4, SDF-1 and Ki67 (Becton Dickinson). Serum concentration of IL-6 and IL-8 were determined by a sequential solid phase chemiluminescent assay performed in a SIEMENS IMMULITE 1000 Analyzer. Statistical analysis was made with the SPSS version 20.0 for Windows. A p value 3/ml) than that in AI (9.2 ± 1.3 × 103/ml) and CI (6.6 ± 1.1 × 103/ml) patients (p p = 0.22 to 0.39), but interestingly in AMI and AI patients, cells were CXCR4+ in almost half of these mobilized cells, although the proportion was significantly higher in AMI patients (46.8% ± 7.1% to 55.7% ± 6.3% vs 23% ± 1.6% to 28.4% ± 2.1%, p = 0.03 to 0.05). A similar behavior was observed with the Ki67 antibody (29.9% ± 2.1% to 36.1% ± 6.3% vs 10% ± 1.2% to 24% ± 1.1%, p = 0.001 to 0.05). Bivariate analysis of the results showed a significant correlation of the cell proportion in AMI but not in AI and CI patients (p = 0.001 to 0.05; 0.12 to 0.87 and 0.17 to 0.92 respectively). The amount of myocardial tissue infarcted did not show any correlation with the amount of cellular subpopulations mobilized to peripheral blood (r = 0.10 to 0.20; p = 0.21 to 0.64) from the bone marrow. Conclusion: The proportion of cellular subpopulations with regenerative potential mobilized to circulation during an event of Acute Myocardial Infarction is significantly higher than during an event of acute angina and chronic stable angina, with a significant proportion of mobilized cells that expressed CXCR4, most of which were already in some of the cell cycle phases.

Highlights

  • The concept that the heart is unable to regenerate has been invalidated with the emergence of cell therapy, and despite multiple clinical trials, it has been difficult to elucidate which subpopulations of bone marrow stem cells, are related to ventricular function improvement, reduction of infarct size, tissue regeneration and angiogenesis [1]-[5].The cellular necrosis process triggers acute inflammatory events with local accumulation of polymorphonuclear cells and acute phase cytokines such as interleukins and Stem Cell Derived Factor 1 (SDF-1)

  • The SDF-1:CXCR4 axis acts upon bone marrow to release stem cells to the blood circulation, especially those which express CXCR4, that are recruited in the myocardial injured

  • In order to try to improve the efficacy of cellular therapy, our aim was to identify and phenotypically characterize, via CXCR4 and SDF-1 expression, the bone marrow cell subpopulations that are mobilized into the bloodstream in a severe inflammatory event, such as Acute Myocardial Infarction (AMI) and acute angina, as well as determine the cell cycle status of these cells

Read more

Summary

Introduction

The cellular necrosis process triggers acute inflammatory events with local accumulation of polymorphonuclear cells and acute phase cytokines such as interleukins and Stem Cell Derived Factor 1 (SDF-1). The latter has shown increases up to 50-fold in the infarct process in experimental models [6]-[9]. Several experimental studies of myocardial infarction have determined a great variety of stem cells with regenerative and angiogenic activity. These cells usually express CD34, CD133, CD117 and their regenerative capacity is enhanced in the presence of growth factors produced by CD48 stem cells [10]-[14]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.